“This is an industry which requires a high level of investment, has relatively high barriers to entry and superior quality requirements compared to other industries,” said Robert Wessman, CEO and ...

Alvogen has had a series of successes in generics, including the launch of a copy of Teva’s Copaxone (glatiramer) multiple sclerosis drug in Europe in August. While oseltamivir is a small ...

US Supreme Court blocks bid to overturn lower court ruling | District court found in 2023 that the generic would infringe ...

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

In a study by the Northwestern Medicine Canning Thoracic Institute in Chicago, the RNA in the SARS-CoV-2 virus was found to "trigger the development of a unique type of immune cell with anti-cancer ...